Sepsis & infection

Operating Room Air Filtration-Sterilization and Surgical Infections: The ORACLE Randomized Trial in 110,538 Surgeries

AnesthesiologyPublished Randomized trial

Primary result · Collapsed composite of surgical wound infections, infection-related complications, or death (inpatients)Result — go to the resultOdds ratio 0.98 95% CI 0.92–1.05

Authors' conclusion

Supplemental active purification did not reduce surgical wound infections or mortality in surgical patients. Infection-control efforts might better focus on limiting direct wound contamination.Trial registration:A priori registration at ClinicTrials.gov: NCT04610294.Funding: Supported by a grant from ActivePure (Bristol, VA) to the Cleveland Clinic. The funder approved the original protocol which was written by the lead author. The funder was not involved in data acquisition, analysis, or manuscript preparation. A draft of the manuscript was provided to the funder as a courtesy.

Study context

Population
Adults who had inpatient or outpatient surgery lasting at least an hour without evidence of pre-existing wound infectionscombined inpatients and outpatients enrolled across 68 operating rooms, 107,334 qualifying for analysis · randomized inpatients 58,938
Participants
110,538 adults
Comparison
Active vs identical-looking sham supplemental air sterilization
Primary endpoint
Collapsed composite of:
  • Surgical wound infections
  • Infection-related complications
  • Death (inpatients)
Follow-up
Within 30 days after inpatient surgery
Methodological detailscluster (operating rooms) randomized in 4-week blocks, sham-controlled, fully blinded, intent-to-treat
  • Cluster (operating rooms) randomized in 4-week blocks
  • Sham-controlled
  • Fully blinded
  • Intent-to-treat

Primary result

As reported in the abstract

Odds ratio

0.98

95% CI 0.92–1.05

P = 0.609

Events by treatment group

Active purification vs Sham purification
odds ratio 0.98 (95% CI 0.92–1.05); P = 0.609

Further findings

OutcomeActive purificationSham purificationOdds ratio (95% CI)P value
Secondary composite outcome, all patients (inpatient and outpatient)5.5%5.6%0.98 (0.93–1.05)P = 0.669

Treatment effect over time

Treatment effect did not vary over the weeks in the randomized periods

Study conduct

At the third interim analysis, the futility boundary on the composite outcome was crossed for inpatients and for all patients; enrollment stopped

Original publication

Operating Room Air Filtration-Sterilization and Surgical Infections: The ORACLE Randomized Trial in 110,538 Surgeries. Anesthesiology. Published 19 October 2026. doi:10.1097/aln.0000000000006424

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.